Propel Bio Management’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$2.27M Hold
2024
Q3
$2.67M Hold
2024
Q2
$1.68M Hold
2024
Q1
$2.27M Hold
2023
Q4
$1.43M Buy